Associations Between Household Mold Levels and Physical and Mental Health: A Mold and Mycotoxin Testing Research Registry

May 18, 2026 updated by: OvationLab
The primary purpose of this study is to evaluate cross-sectional associations between mold exposures identified with The Dust Test and self-reported physical health, emotional health, and medical diagnoses. In addition, associations between mold exposures and mycotoxin levels among users who have done mycotoxin lab testing will also be evaluated.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

2500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Virginia
      • Richmond, Virginia, United States, 23220
        • OvationLab
        • Contact:
          • Study Administration
          • Phone Number: ‪(240) 232-2103‬

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.

Description

Inclusion Criteria:

  • All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.

Exclusion Criteria:

  • Dust Test users who do not provide informed consent for deidentified analysis and peer-reviewed publication of their data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROMIS - Global Health
Time Frame: Assessed at the time that the mold test is collected (cross-sectional)
Ten questions assessing physical and mental health. Higher scores indicate superior physical and mental health.
Assessed at the time that the mold test is collected (cross-sectional)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mold-related symptoms
Time Frame: Assessed at the time that the mold test is collected (cross-sectional)
A set of 41 potentially mold-related symptoms. Higher scores indicated worse symptoms.
Assessed at the time that the mold test is collected (cross-sectional)
Mycotoxin levels
Time Frame: Assessed at the time that the mold test is collected (cross-sectional)
Urinary mycotoxin levels will be assessed. Higher levels indicated greater mycotoxin presence.
Assessed at the time that the mold test is collected (cross-sectional)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

OvationLab

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 27, 2026

Primary Completion (Estimated)

April 1, 2029

Study Completion (Estimated)

April 1, 2029

Study Registration Dates

First Submitted

May 18, 2026

First Submitted That Met QC Criteria

May 18, 2026

First Posted (Actual)

May 22, 2026

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • TDT - 001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Mold results and participant-reported outcomes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mold or Dust Allergy

Clinical Trials on Mold-specific quantitative PCR (MSQPCR) testing

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe